Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.
Janson
E Tiensuu
ET
Department of Medical Sciences, University Hospital, Uppsala, Sweden. eva.tiensuu_janson@medsci.uu.se
Oberg
Kjell
K
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D006801:Humans; D018358:Neuroendocrine Tumors / Q000188:drug therapy* / Q000235:genetics; D015282:Octreotide / Q000627:therapeutic use*; D017481:Receptors, Somatostatin / Q000235:genetics*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D017481:Receptors, Somatostatin; D013004:Somatostatin; D015282:Octreotide